Wolfschlugen
Germany
71
2026-04-16
The entities that hold a legal rights for patent applications filed by inventor Probst Jochen:
Jochen Probst from Wolfschlugen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
COMBINATION OF VACCINATION AND INHIBITION OF THE PD-1 PATHWAY
#2 | 2025-11-20NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED PATHOGENIC ANTIGEN
#3 | 2025-07-03RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES
#4 | 2025-05-15NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED PROTEIN
#5 | 2023-10-26RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES
#6 | 2023-07-06PRIME-BOOST REGIMENS INVOLVING ADMINISTRATION OF AT LEAST ONE mRNA CONSTRUCT
#7 | 2023-05-25COMBINATION OF VACCINATION AND INHIBITION OF THE PD-1 PATHWAY
#8 | 2023-02-23Method for producing RNA
#9 | 2022-12-22NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS IMMUNOSTIMULATING AGENT/ADJUVANT
#10 | 2022-11-24RNA-CODED ANTIBODY
#11 | 2022-05-19METHOD FOR PRODUCING RNA
#12 | 2022-03-31COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC)
#13 | 2021-12-23NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED TUMOUR ANTIGEN
#14 | 2021-05-06Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
#15 | 2021-03-04NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED THERAPEUTIC PROTEIN
#16 | 2020-11-05Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
#17 | 2020-10-01Method for producing RNA
#18 | 2020-09-03Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein
#19 | 2020-03-19NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS IMMUNOSTIMULATING AGENT/ADJUVANT
#20 | 2020-01-16NUCLEIC ACID OF FORMULA (I): GlXmGn, OR (II): ClXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT
#21 | 2019-12-19Combination of vaccination and inhibition of the PD-1 pathway
#22 | 2019-12-05Composition for treating prostate cancer (PCa)
#23 | 2019-09-19RNA-CODED ANTIBODY
#24 | 2019-08-22NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED ALLERGENIC ANTIGEN OR AN AUTOIMMUNE SELF-ANTIGEN
#25 | 2019-05-23RNA containing composition for treatment of tumor diseases
#26 | 2019-02-21RNA containing composition for treatment of tumor diseases
#27 | 2018-10-04Method for producing RNA
#28 | 2018-09-27Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
#29 | 2018-09-13COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC)
#30 | 2018-07-26RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES
#31 | 2018-07-05Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
#32 | 2018-06-28Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
#33 | 2018-06-21Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
#34 | 2018-06-21Combination of vaccination and inhibition of the PD-1 pathway
#35 | 2018-06-21Combination of vaccination and inhibition of the PD-1 pathway
#36 | 2018-06-14Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
#37 | 2018-05-10Prime-boost regimens involving administration of at least one mRNA construct
#38 | 2018-03-01Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein
#39 | 2017-07-13Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
#40 | 2017-03-02Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
#41 | 2017-01-05COMPOSITION FOR TREATING PROSTATE CANCER (PCa)
#42 | 2016-12-01COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC)
#43 | 2016-11-17RNA containing composition for treatment of tumor diseases
#44 | 2016-11-10Method for producing RNA
#45 | 2016-11-03COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC)
#46 | 2016-10-20Composition for treating prostate cancer (PCa)
#47 | 2016-09-01NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS IMMUNOSTIMULATING AGENT/ADJUVANT
#48 | 2016-07-21Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
#49 | 2016-07-21COMBINATION OF VACCINATION AND INHIBITION OF THE PD-1 PATHWAY
#50 | 2016-06-30RNA-CODED ANTIBODY
#51 | 2016-06-16RNA-CODED ANTIBODY
#52 | 2016-06-16RNA-CODED ANTIBODY
#53 | 2016-06-16RNA-CODED ANTIBODY
#54 | 2016-06-16RNA-CODED ANTIBODY
#55 | 2016-06-02RNA-CODED ANTIBODY
#56 | 2016-06-02RNA-CODED ANTIBODY
#57 | 2016-05-26RNA-CODED ANTIBODY
#58 | 2016-05-12Combination of vaccination and inhibition of the PD-1 pathway
#59 | 2015-11-12Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
#60 | 2015-06-18Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded allergenic antigen or an autoimmune self-antigen
#61 | 2015-04-02Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
#62 | 2015-02-26Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
#63 | 2013-09-26Composition for treating prostate cancer (PCa)
#64 | 2013-08-08Composition for treating lung cancer, particularly of non-small lung cancers (NSCLC)
#65 | 2013-08-01RNA-CODED ANTIBODY
#66 | 2013-05-23Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein
#67 | 2012-01-26Nucleic acids comprising formula (NGXGN)and derivatives thereof as immunostimulating agent/adjuvant
#68 | 2010-12-02COMPOSITION FOR TREATING PROSTATE CANCER (PCa)
#69 | 2010-11-18COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC)
#70 | 2010-07-29RNA-coded antibody
#71 | 2009-12-31Nucleic Acid of Formula (I): GIXmGn, or (II): CIXmCn, in Particular as an Immune-Stimulating Agent/Adjuvant
260902 ⎘